Tirzepatide 30mg Pen Refill Vial

Tirzepatide is a dual GIP and GLP-1 receptor agonist that offers significant benefits, including substantial weight loss (up to 20.9% of body weight) and improved glycemic control. It reduces appetite, slows digestion, lowers blood pressure, and improves lipid levels. It is used for Type 2 diabetes and weight management.

Key Health Benefits 

• Significant Weight Loss: Clinical trials show that individuals taking tirzepatide can lose between 5% and 20.9% of their body weight, depending on the dosage, by reducing appetite and increasing satiety. 
• Improved Glycemic Control: It effectively treats Type 2 diabetes by enhancing insulin sensitivity and reducing blood sugar levels, often outperforming older, single-action medications. 
• Cardiovascular Health Improvement: Studies indicate it can lower blood pressure and improve lipid profiles, reducing the risk of cardiovascular events. 
• Reduced Liver Fat: Tirzepatide has shown a significant ability to reduce liver fat content in patients with Type 2 diabetes. 
• Potential for Treating PCOS: By improving insulin resistance, it may help manage symptoms of polycystic ovary syndrome (PCOS), including promoting weight loss and helping to stabilize menstrual cycles. 
• Reduced Inflammation: Emerging evidence suggests it may help reduce systemic inflammation.

Information:

Tirzepatide 30mg Refill Vial For Reusable Pen

Concentration

30mg

Dosage

Starting Dose : 2.5mg